Page last updated: 2024-10-30

lamotrigine and Basal Ganglia Diseases

lamotrigine has been researched along with Basal Ganglia Diseases in 6 studies

Basal Ganglia Diseases: Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA.

Research Excerpts

ExcerptRelevanceReference
"Aripiprazole is an atypical antipsychotic compound that is approved by the U."6.73Aripiprazole therapy in 20 older adults with bipolar disorder: a 12-week, open-label trial. ( Blow, FC; Cassidy, KA; Coconcea, N; Hays, RW; Ignacio, RV; Meyer, WJ; Sajatovic, M, 2008)
"We report the case of a 16-year-old male with Mucopolysaccharidosis III type A (Sanfilippo syndrome) who was commenced on risperidone for behaviour management."3.75Extrapyramidal symptoms and medication use in Mucopolysaccharidosis type III. ( Sillence, D; Tchan, MC, 2009)
"Aripiprazole is an atypical antipsychotic compound that is approved by the U."2.73Aripiprazole therapy in 20 older adults with bipolar disorder: a 12-week, open-label trial. ( Blow, FC; Cassidy, KA; Coconcea, N; Hays, RW; Ignacio, RV; Meyer, WJ; Sajatovic, M, 2008)
"Weight gain was found to be lower in the elderly for antipsychotic drugs, in particular for olanzapine."1.39Age and adverse drug reactions from psychopharmacological treatment: data from the AMSP drug surveillance programme in Switzerland. ( Baumann, P; Greil, W; Grohmann, R; Häberle, A; Schuhmann, T, 2013)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (66.67)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Greil, W1
Häberle, A1
Schuhmann, T1
Grohmann, R1
Baumann, P1
Marrero-Gonzalez, PC1
Ruano, OL1
Catalano, G1
Catalano, MC1
Tchan, MC1
Sillence, D1
Arpin, S1
Lagrue, E1
Bodard, S1
Chalon, S1
Castelnau, P1
Derry, S1
Moore, RA1
Sajatovic, M1
Coconcea, N1
Ignacio, RV1
Blow, FC1
Hays, RW1
Cassidy, KA1
Meyer, WJ1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Aripiprazole in Late Life Bipolar Disorder[NCT00194038]Phase 420 participants (Actual)Interventional2004-04-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

1 review available for lamotrigine and Basal Ganglia Diseases

ArticleYear
Atypical antipsychotics in bipolar disorder: systematic review of randomised trials.
    BMC psychiatry, 2007, Aug-16, Volume: 7

    Topics: Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Bipolar Disorder; Depressive Disorder

2007

Trials

1 trial available for lamotrigine and Basal Ganglia Diseases

ArticleYear
Aripiprazole therapy in 20 older adults with bipolar disorder: a 12-week, open-label trial.
    The Journal of clinical psychiatry, 2008, Volume: 69, Issue:1

    Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Bipolar Disorde

2008

Other Studies

4 other studies available for lamotrigine and Basal Ganglia Diseases

ArticleYear
Age and adverse drug reactions from psychopharmacological treatment: data from the AMSP drug surveillance programme in Switzerland.
    Swiss medical weekly, 2013, Volume: 143

    Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Age Factors; Aged; Aged, 80 and over; An

2013
Dystonia associated with lamotrigine therapy: a case report and review of the literature.
    Current drug safety, 2014, Volume: 9, Issue:1

    Topics: Antidepressive Agents; Basal Ganglia Diseases; Dystonia; Humans; Lamotrigine; Male; Middle Aged; Moo

2014
Extrapyramidal symptoms and medication use in Mucopolysaccharidosis type III.
    Journal of intellectual & developmental disability, 2009, Volume: 34, Issue:3

    Topics: Adolescent; Adult; Anticonvulsants; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; C

2009
Basal ganglia neuroprotection with anticonvulsants after energy stress: a comparative study.
    Metabolic brain disease, 2009, Volume: 24, Issue:3

    Topics: Animals; Anticonvulsants; Autoradiography; Basal Ganglia; Basal Ganglia Diseases; Dopamine Plasma Me

2009